thalidomide has been researched along with Cold Panniculitis in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy." | 5.43 | Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis. ( Fung, MA; Jagdeo, J; Mayo, K; Petukhova, TA; Tartar, DM; Tuscano, J, 2016) |
| "Erythema nodosum (EN) is a panniculitis frequently encountered secondary to medical therapy." | 1.43 | Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis. ( Fung, MA; Jagdeo, J; Mayo, K; Petukhova, TA; Tartar, DM; Tuscano, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abril-Pérez, C | 1 |
| Palacios-Diaz, RD | 1 |
| Navarro-Mira, MÁ | 1 |
| Botella-Estrada, R | 1 |
| Bathula, S | 1 |
| Sardana, K | 1 |
| Mathachan, SR | 1 |
| Khurana, A | 1 |
| Ahuja, A | 1 |
| Paliwal, P | 1 |
| Nakamitsu, PZ | 1 |
| Compri, CM | 1 |
| de Fraia Pinto, L | 1 |
| Gotardo, ÉM | 1 |
| de Oliveira, CC | 1 |
| Ribeiro, ML | 1 |
| Pedrazzoli, J | 1 |
| Gambero, A | 1 |
| Petukhova, TA | 1 |
| Tartar, DM | 1 |
| Mayo, K | 1 |
| Fung, MA | 1 |
| Tuscano, J | 1 |
| Jagdeo, J | 1 |
4 other studies available for thalidomide and Cold Panniculitis
| Article | Year |
|---|---|
Successful treatment of erythema nodosum leprosum with apremilast.
Topics: Erythema Nodosum; Humans; Leprosy, Lepromatous; Leprosy, Multibacillary; Panniculitis; Thalidomide | 2022 |
A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
Topics: Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Leprosy, Multibacillary; Pannicu | 2023 |
Thalidomide controls adipose tissue inflammation associated with high-fat diet-induced obesity in mice.
Topics: 3T3-L1 Cells; Adipogenesis; Adipokines; Adipose Tissue; Adiposity; Animals; Anti-Inflammatory Agents | 2015 |
Erythema Nodosum-like Septal Panniculitis Secondary to Lenalidomide Therapy in a Patient With Janus Kinase 2-Positive Myelofibrosis.
Topics: Aged; Erythema Nodosum; Humans; Immunologic Factors; Janus Kinase 2; Lenalidomide; Male; Panniculiti | 2016 |